Back
IQVIA Holdings Vs. Summit Therapeutics Industry Stock Comparison
Sell
43
IQV
IQVIA Holdings
Last Price:
219.09
Seasonality Move:
4.99%
Buy
65
SMMT
Summit Therapeutics
Last Price:
21.41
Seasonality Move:
43.75%
Sell
43
IQVIA Holdings (IQV)
is a Sell
Is IQVIA Holdings a Buy, Sell or Hold?
- The current IQVIA Holdings [IQV] share price is $219.23. The Score for IQV is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- IQV is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
65
Summit Therapeutics (SMMT)
is a Buy
Is Summit Therapeutics a Buy, Sell or Hold?
- The current Summit Therapeutics [SMMT] share price is $21.41. The Score for SMMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- SMMT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IQV Stock Price Chart
What is IQVIA Holdings's stock price today?
-
The IQVIA Holdings share price today is $219.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IQV is experiencing slight selling pressure.
SMMT Stock Price Chart
What is Summit Therapeutics's stock price today?
-
The Summit Therapeutics share price today is $21.41
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMMT is experiencing slight buying pressure.
IQV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.61 | Sell |
| Relative Strength Index (14 RSI): | 46.49 | Sell |
| Chaikin Money Flow: | -85597 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (213.89 - 231.43) | Sell |
| Bollinger Bands (100): | (217.79 - 243.57) | Sell |
SMMT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.16 | Buy |
| Relative Strength Index (14 RSI): | 54.59 | Buy |
| Chaikin Money Flow: | 421167 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.05 - 21.57) | Buy |
| Bollinger Bands (100): | (9.09 - 21.39) | Buy |
IQV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 214.03 | Buy |
| 20-day SMA: | 221.27 | Sell |
| 50-day SMA: | 231.35 | Sell |
| 200-day SMA: | 232.19 | Sell |
| 8-day EMA: | 216.67 | Buy |
| 20-day EMA: | 220.16 | Sell |
| 50-day EMA: | 226.92 | Sell |
| 200-day EMA: | 228.34 | Sell |
SMMT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20 | Buy |
| 20-day SMA: | 20.63 | Buy |
| 50-day SMA: | 20.55 | Buy |
| 200-day SMA: | 9.96 | Buy |
| 8-day EMA: | 20.63 | Buy |
| 20-day EMA: | 20.49 | Buy |
| 50-day EMA: | 19.23 | Buy |
| 200-day EMA: | 11.98 | Buy |
IQVIA Holdings Earnings Growth & IQV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.95 per share, and an increase next year of $1.05 per share.
Summit Therapeutics Earnings Growth & SMMT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and a decrease next year of $0.08 per share.
IQVIA Holdings Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Summit Therapeutics Technical Analysis
| Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||